BCTXW

BriaCell Therapeutics Corp. Warrant (BCTXW)

About BriaCell Therapeutics Corp. Warrant (BCTXW)

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company, which engages in the development of immunotherapies for the treatment of cancer. Its technologies include Bria-IMT and Bria-OTS. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

Details

Daily high
$0.38
Daily low
$0.30
Price at open
$0.35
52 Week High
$2.60
52 Week Low
$0.11
Market cap
--
Dividend yield
0.00%
Volume
132,583
Avg. volume
138,916
P/E ratio
--

BriaCell Therapeutics Corp. Warrant News

Details

Daily high
$0.38
Daily low
$0.30
Price at open
$0.35
52 Week High
$2.60
52 Week Low
$0.11
Market cap
--
Dividend yield
0.00%
Volume
132,583
Avg. volume
138,916
P/E ratio
--